Munster Medicaid paid $54,193 for COVID-19-related claims in 2024

Munster Medicaid reimbursements totaled no less than $54,193 in 2024 for services coded specifically for COVID-19, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid is a public insurance program administered at the state level and financed through a partnership between federal and state governments. Its coverage extends to low-income people and families, seniors, children, and individuals with disabilities, making it a leading part of the nation’s health care landscape.

Changes in Medicaid billing at the community level provide insight into how taxpayer-based public health resources are distributed.

COVID-19–related claims were tracked using HCPCS codes classified or described as “COVID-19” or “coronavirus”-specific in the relevant billing details or reference files. Therefore, these amounts include only spending on services directly designated as COVID-related, not other pandemic care possibly entered under broader medical classifications.

By comparison, Hammond led Indiana’s cities for Medicaid COVID-19 claims in 2024, with $443,500 submitted for virus-related services.

Two Munster providers billed Medicaid for COVID-19–specific services in 2024. The Immunoassay code ranked as most utilized, with claims totaling $46,405.

Munster’s average Medicaid COVID-19 payment per provider came to $27,096—surpassing Indiana’s statewide average of $17,610.

Throughout the pandemic years, COVID-19–targeted services made up a sizable factor in the surge of Medicaid outlays in Munster.

In other claim categories, total Medicaid spending climbed by $6,138,434 from 2020 to 2024—a 72.5% jump.

The average annual Medicaid payment in Munster during the two years before the pandemic was $7,461,674.

According to the Centers for Medicare & Medicaid Services, total federal and state Medicaid expenditures hit around $871.7 billion in fiscal 2023, or nearly 18% of all U.S. health spending—an increase from $613.5 billion in 2019, before the COVID-19 crisis began.

This represents a roughly 40% jump within a span of just a few years, principally caused by increased enrollment and utilization through the pandemic and its aftermath.

Sweeping budgetary measures passed under the Trump administration have included major reductions and restructuring plans for federal Medicaid. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid funding by more than $1 trillion across the next decade. It brings changes such as adding work requirements and greater beneficiary cost-sharing, potentially reducing access and funding for some enrollees. These adjustments would shift additional costs to states and curb federal Medicaid expenditure growth, though the program is projected to cover tens of millions of Americans moving forward.

Note: Includes only HCPCS codes formally labeled as for COVID-19 services; this is not a comprehensive accounting of all health care spending linked to the pandemic.

Details for this report use public records from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Access the original dataset here.